retraction of the left upper eyelid, and bilateral ocular redness with eyelid oedema since 8 months (Figure 1a and b). The levator function of the right eye was 3 mm and there was complete blepharoptosis. Elevation was bilaterally restricted, with duction values of 25 degrees. Fundoscopy showed tortuosity of the veins and papillary oedema in the right eye. The visual acuity was 6/9 OD and 6/6 OS, respectively. Exophthalmometry readings were 19 mm bilaterally.
Laboratory investigations revealed autoimmune hyperthyroidism. Orbital CT scan examination showed bilateral thickening of rectus muscles (Figure 2a) . We ruled out myasthenia gravis and intracranial lesions. Despite treatment with oral and intravenous steroids his orbitopathy progressed. Consequently, he underwent bilateral transconjunctival inferomedial orbital decompression. Postoperatively, the blepharoptosis and signs of bilateral optic nerve compression resolved over a period of 5 months (Figure 2b ). Subsequently, bilateral upper eyelid retraction was noted (Figure 1c ).
Comment
We hypothesize that the blepharoptosis was caused by a first degree injury due to compression and ischaemia of the branch of the oculomotor nerve supplying the Levator in the orbit. In first-degree oculomotor nerve injuries, which frequently result from microvascular obstruction, the continuity of the axons is maintained. 2 Hence, full function returns once the flow is restored. The aetiology of the oculomotor nerve compression could be similar to that of optic nerve compression induced by apical crowding in a particularly tight orbit. 3, 4 Hence, blepharoptosis in a patient with thyroid orbitopathy may indicate apical compression. Sir, Inadvertent injection of intravitreal air during intravitreal Lucentis injection for wet age-related macular degeneration: an undescribed complication
The frequency of intravitreal injections is increasing after landmark age-related macular degeneration studies, 1, 2 and to a lesser extent evidence for the efficacy of intravitreal triamcinolone for diabetic maculopathy.
3 Several uncommon complications are described, namely infectious and non-infectious endophthalmitis, iatrogenic lesions to the intraocular structures leading to retinal detachment or cataract and steroid-induced glaucoma. 4 Two patients receiving intravitreal ranibizumab (Lucentis) for wet age-related macular degeneration complained immediately after their injection of unusual visual symptoms, 'like looking through an hour glass,' particularly when looking down. Ocular examination revealed multiple small intravitreal air bubbles with no entry site breaks or vitreous floaters. This is an important observation for several reasons. Most importantly, these bubbles produced disturbing symptoms in the patients that they were not expecting. Air within the syringe could also alter the administered dose of the drug. Finally, it is well documented that intravitreal gas presents a risk during air flight. 5 The volume involved here is low, but we should be aware that this is a potential complication of intravitreal injections and should take appropriate measures to avoid these symptoms and potential complications by actively checking the syringe and needle before injection to ensure that no air has been drawn up when preparing the drug for injection.
